Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022March 2, 2022 Emyria saw sales revenue decline by a third in the first six months of the financial […]
UNSW and e3D Pharma join forces to test treatment potential of cannabinoids for PTSD and anxiety by Martin Lane June 28, 2021June 28, 2021
Hope for cannabis campaigners as royal commission is launched into veteran suicides by Steve Jones April 20, 2021April 20, 2021
Plight of PTSD victim stirs support as momentum builds to help stricken military veterans by Steve Jones April 8, 2021June 9, 2021
